Categories Technology

Ali Health’s surprise stock recovery raises eyebrows

A week earlier, many analysts were scratching their heads on why a small unit of Alibaba (BABA) became a top stock performer. By May 17, Alibaba Health Information Technology had soared at least 56% in six days, making it one of the healthiest stocks in the world. But then, last Tuesday, the unit announced a $1.4 billion deal to acquire a part of the health-based assets of its parent, the e-commerce giant – raising many eyebrows.

When news of the deal officially broke, the Alibaba unit saw its stock rise 3.8% to about HK$ 7 per share. The deal is also expected to boost Ali Health further, with more pharma-related business flowing back to it from its parent, Alibaba. According to the terms of the deal, Alibaba will have about 67% voting rights in Ali Health.

Ali Health sees stock surge a week before major deal

 

Last week, Alibaba Health announced a $1.4-billion deal to acquire pharma assets of its parent, Alibaba Group

The unit was operating at a loss a year ago but did a turnaround so swiftly that it became a top gun of the MSCI Asia Pacific Index. However, this has also made many investors approach the stock with some apprehension and caution.

Alibaba units other than Ali Health also saw quick jumps, with Alibaba Pictures recording a 32% hike last Thursday in the Honk Kong exchange.

According to many reports, no regulators have yet come out with any official announcements regarding the unusual stock surge. So it could also be that the stock grew organically due to the fact that it is, indeed, part of Jack Ma’s ever-growing empire.

Ali Health sees yearly high on deal with parent Alibaba

Most Popular

IPO Alert: What to look for when Boundless Bio goes public

Boundless Bio is preparing to debut on the Nasdaq stock market this week, and become the latest addition to the list of biotech firms that have launched IPOs this year.

Nike (NKE) bets on innovation and partnerships to return to high growth

Sneaker giant Nike, Inc. (NYSE: NKE) has been going through a rough patch for some time, with sales coming under pressure from weak demand and rising competition. Post-pandemic, the company

Walgreens Boots Alliance set to report earnings next week. Here’s what to expect

Walgreens Boots Alliance, Inc. (NASDAQ: WBA), the drug store chain that is expanding into a diversified healthcare provider, is on a restructuring drive aimed at better aligning the business with

Tags

Add Comment
Loading...
Cancel
Viewing Highlight
Loading...
Highlight
Close
Top